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Background: Sonchus asper (SA) is traditionally used as a folk medicine to treat mental disorders in Pakistan. The
aim of this study was to investigate the effect of polyphenolic rich methanolic fraction of SA on cognitive
performance, brain antioxidant activities and acetylcholinesterase activity in male rats.
Methods: 30 male Sprague–Dawley rats were equally divided into three groups in this study. Animals of group I
(control) received saline (vehicle), group II received SA (50 mg/kg) body weight (b.w.), and group III treated with SA
(100 mg/kg b.w.,) orally in dimethyl sulphoxide (DMSO) for 7 days. The effect of SA was checked on rat cognitive
performance, brain antioxidatant and acetylcholinesterase activities. Evaluation of learning and memory was
assessed by a step-through a passive avoidance test on day 6 after two habituation trials and an initial acquisition
trial on day 5. Antioxidant potential was determined by measuring activities of superoxide dismutase (SOD), catalase
(CAT), contents of thiobarbituric acid reactive substances (TBARS) and reduced glutathione (GSH) in whole-brain
homogenates. Acetylcholinesterase (AChE) activity was determined by the colorimetric method.
Results: Results showed that 100 mg/kg b.w., SA treated rats exhibited a significant improvement in learning and
memory (step-through latency time). SA administration reduced lipid peroxidation products and elevated
glutathione levels in the SA100-treated group. Furthermore, salt and detergent soluble AChE activity was
significantly decreased in both SA-treated groups. Short-term orally supplementation of SA showed significant
cognitive enhancement as well as elevated brain antioxidant enzymes and inhibited AChE activity.
Conclusion: These findings stress the critical impact of Sonchus asper bioactive components on brain function.
Keywords: Sonchus asper, Cognitive performance, Acetylcholinesterase activity, Antioxidant enzymesBackground
Alzheimer’s disease (AD) is a slowly progressive disease
of the brain that is characterized by the impairment of
memory and eventually by disturbances in reasoning,
planning, language, and perception. Amyloid β-peptide
(Aβ) has been identified as a possible source of oxidative
stress in AD because it can acquire a free-radical state
that contributes to its toxic effects. Aβ-induced cytotox-
icity is caused by intracellular accumulation of reactive* Correspondence: rahmatgul_81@yahoo.com
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in any medium, provided the original work isoxygen species, which leads to lipid peroxidation and cell
death [1]. Although the precise mechanisms by which
Aβ induces neurotoxicity is still unknown, modulation of
Aβ insult has been speculated to be an important pre-
ventive and neuro protective approach to control the
onset of AD [2]. Use of antioxidants has been recognized
as an effective method in minimizing pathological and
toxic effects associated with Aβ-induced oxidative stress.
Medicinal plants play a crucial role in the treatment of
AD. Ginkgo biloba L. [3], Huperzia serrata (Thunb. Ex
Murray) Trevis. [4] and salvianolic acid B [5] has been
extensively investigated as natural therapeutic agents for
the treatment of AD patients. Previous results revealed
that memory dysfunction and cognitive deficits were sig-
nificantly controlled with nutrient supplementation [6,7].s is an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
properly cited.
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inflammatory mediator and nitric oxide (NO) as well as
lipid peroxidation in rats [8]. The central cholinergic sys-
tem is essential for the regulation of cognitive functions,
as evidenced by the extensive loss of cholinergic neurons
observed in the forebrain of Alzheimer’s patients. Many
anticholinergic drugs such as scopolamine cause learning
and memory deficits in a variety of cognitive animal
models [9,10]. Agonists of cholinergic receptors and
inhibitors of AChE have been extensively used in order
to increase endogenous acetylcholine levels and thus
overcome cognitive deficits. Acetylcholinesterase meta-
bolizes acetylcholine to choline and acetyl-CoA, which
exist into asymmetric forms and globular (G) forms. The
G1 form is cytosolic and G4 form is membrane bound
by hydrophobic amino acid sequences or glycophospholi-
pids. The detergent soluble (DS) and salt soluble (SS)
fraction of AChE contains predominantly G4 and G1
forms [11].
Fruits, vegetables and medicinal plant bioactive meta-
bolites play a key role in the slowing of many pathogen-
esis and neurodegenerative disorders such as Alzheimer
and dementia [12,13]. Daily consumption of fresh
vegetable reported in delaying of cognitive decline in
older age [14]. Beneficial effects of these metabolites are
proposed to associate with potentiating of antioxidant
defenses, which is linked to normal aging and neurode-
generative diseases [15]. Sonchus asper (SA) has been
traditionally used in the treatment of wound [12],
oxidative dysfunction, bronchitis and asthma [13], cen-
tral nervous system dysfunction, mental disorders [11],
might be due to the presence of phenolic compounds,
ascorbic acid and carotenoids [14,15]. Phenolic com-
pounds have anticholinesterase activities, which might be
valuable for the treatment of AD [16]. Due to the pres-
ence of phenolic compounds in SA, the present study
was arranged to investigate the effect of SA on cognitive
performance, antioxidant activities of brain homogenate,
TBARS, GSH content and AChE activity.Materials and methods
Plant material
Aerial parts (leaves, stem, flowers and seeds) of SA were
collected and their specimen was submitted at Herbarium
of Pakistan (Quaid-i-Azam University Islamabad, Pakistan).
They were shade dried at room temperature, chopped and
ground mechanically to a mesh size of 1 mm.Preparation of plant extracts
One kg dried sample of SA was extracted twice with 4 l
of absolute methanol at 25°C. The extracts were filtrated
through Whatman No. 1 fiter paper and concentrated
using a rotary evaporator (Panchun Scientific Co.,Kaohsiung, Taiwan) under reduced pressure at 40°C. The
dried extract was stored at 4°C for in-vivo investigations.
In-vitro acetylcholinesterase inhibition assay
The assay for AChE activity was conducted using the
method of Ellman et al. [17], having acetylthiocholine
iodide (ATCI) as a substrate. The rate of production of
thiocholine is determined by the continuous reaction of
the thiol with 5,5-dithiobis-2-nitrobenzoate (DTNB) ion
to produce the yellow anion of 5-thio-2- nitro-benzoic
acid. Briefly, in the 96well plates, 25 μl of 15 mM ATCI,
75 μl of 3 mM DTNB and 50 μl of 50 mM Tris HCl, pH
8.0, containing 0.1% bovine serum albumin (BSA), and
25 μl of SA (5–150 μg/ml) was added and the absorb-
ance was measured at 405 nm after 5 min of incubation
at room temperature. After 25 μl of 0.22 U/ml of AChE
from electric eel (Sigma–Aldrich Corporation, St. Louis,
MO, USA) was added, the absorbance was measured
again after 5 min of incubation at room temperature.
Percentage of inhibition was calculated by comparing the
rate of enzymatic hydrolysis of ATCI for the samples to
that of the blank (50% aqueous methanol in the buffer).
Galanthamine (1–32 μM) was used as a reference stand-
ard and was supplied by Sigma–Aldrich. All determina-
tions were carried out at least five times, and in
triplicate, at each concentration of the standard and
samples.
Animals
30 Male, albino rats (180–190 g, b.w.), were provided by
National Institute of Health Islamabad and were kept in
ordinary cages at room temperature of 25 ± 3°C with a
12 h dark/light cycle. They were allowed free access to
food in form of dry pellets and water and randomly
divided into three groups: a vehicle group (n = 10) (Con-
trol), SA-treated group (n = 10) with SA 50 mg/kg b.w.
(SA 50) and SA-treated group (n = 10) with 100 mg SA/
kg b.w., (SA100). The SA extract was administered orally
daily to SA50 and SA100 groups at a final volume
200 μl, while rats in the C group received 200 μl of sa-
line. The study protocol was approved by Ethical
Committee of Quaid-I-Azam University Islamabad for
laboratory animal feed and care.
2.5. Behavioral testing: step-through a passive avoidance
task
Rats were subjected to a step-through test on day 6, after
a double training and an initial acquisition trial on day 5.
It was performed according to previously described pro-
cedures, using a two-compartment passive avoidance
apparatus (white/dark, separated by a black wall with a
guillotine door in the middle part), with minor modifica-
tions of the time intervals. In detail, on day 5, the ani-
mals were allowed to habituate in the experimental room
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was placed in the illuminated chamber for the acquisi-
tion trial and was left to habituate to the apparatus. One
hundred seconds later, the guillotine door was opened,
and the animal was allowed to enter the dark compart-
ment. The latency with which the animal crossed into
the dark compartment was recorded. Animals that
waited more than 100 s to enter the dark compartment
were eliminated from the experiments. Once the animal
crossed with all four paws to the next compartment, the
guillotine door was closed, and the rat was taken into its
home cage. The trial was repeated after 30 min as in the
acquisition trial, where after 5 s the guillotine door was
opened and as soon as the animal crossed to the dark
compartment the door was closed and a foot shock
(25 V, 3 mA, 5 s) was immediately delivered to the grid
floor of the dark room. Thereafter, the rat was immedi-
ately removed from the apparatus and returned to its
home cage. In this trial, the initial latency (IL) of en-
trance into the dark chamber was recorded (maximum
time allowed was 120 s). Twenty-four hours after train-
ing, a retention test was performed to determine long-
term memory. Each animal was placed in the light com-
partment for 20 s. The door was opened, and the step-
through latency (STL) was measured for entering into
the dark compartment. The test session ended when the
animal entered the dark compartment or remained in
the light compartment for 300 s (criterion for retrieval).
During these sessions, no electric shock was applied. All
training and testing sessions were carried out during the
light phase between 08:00 and 14:00 h.
Ex vivo assessment of antioxidant enzymes
After completions of experiment rats were killed, and
whole intact brain was carefully removed and incubated
on an ice chilled for cleaning. The cerebellum was sepa-
rated immediately while rest of brain tissue was homoge-
nized in a phosphate buffer (pH 7.6), centrifuged at
20,000 × g, 4◦C for 2 h to obtain a soluble salt part (SS).
Re-extraction of the pellets was carried out to get a sol-
uble detergent part (DS) [18]. The supernatant was col-
lected and stored at −20◦C. Protein concentrations were
determined by the Bradford assay with Bovine serum al-
bumin as standard (0.05–1.00 mg/ml).
AChE assessment
AChE activity was determined using the colorimetric
assay of Ellman et al. [17], as previously described.
Briefly, in the 96 well plates, 25 μl of 15 mM ATCI, 75 μl
of 3 mM DTNB and 75 μl of 50 mM Tris–HCl, pH 8.0,
containing 0.1% BSA, were added and the absorbance
was read at 405 nm after five min incubation at room
temperature. Any increase in absorbance due to the
spontaneous hydrolysis of the substrate was corrected bysubtracting the rate of the reaction before adding the en-
zyme. Then, 25 μl of sample (SS and DS fraction of brain
homogenates) was added, and the absorbance was read
again after 5 min of incubation at room temperature.
The AChE activity is expressed as mol/min/g of tissue
protein. All determinations were carried out twice and in
triplicate.
Catalase assay (CAT)
CAT activities were determined with reaction solution
contained: 2.5 ml of 50 mmol phosphate buffers
(pH 5.0), 0.4 ml of 5.9 mmol H2O2 and 0.1 ml tissue
homogenate. Changes in absorbance of the reaction solu-
tion at 240 nm were determined after one minute. One
unit of catalase activity was defined as an absorbance
change of 0.01 as units/min [19].
Superoxide dismutase assay (SOD)
SOD activity was estimated by the method of Kakar
et al. [20]. Reaction mixture of this method contained:
0.1 ml of phenazine methosulphate (186 μmol), 1.2 ml of
sodium pyrophosphate buffer (0.052 mmol; pH 7.0),
0.3 ml of the supernatant after centrifugation (1500 × g
for 10 min followed by 10,000 × g for 15 min) of hom-
ogenate was added to the reaction mixture. Enzyme reac-
tion was initiated by adding 0.2 ml of NADH (780 μmol)
and stopped after 1 min by adding 1 ml of glacial acetic
acid. Amount of chromogen formed was measured by
recording color intensity at 560 nm. Results are
expressed in units/mg protein.
Glutathione-S-transferase assay (GST)
The glutathione-S-transferase activity mixture consisted
of 1.475 ml phosphate buffer (0.1 mol, pH 6.5), 0.2 ml
reduced glutathione (1 mmol), 0.025 ml 1-Chloro-2,4-
dinitrobenzene (CDNB) (1 mmol) and 0.3 ml of hom-
ogenate in a total volume of 2.0 ml. The changes in the
absorbance were recorded at 340 nm and enzymes activ-
ity was calculated as nmol CDNB conjugate formed/
min/mg protein using a molar extinction coefficient of
9.6 × 103 M-1 cm-1 [21].
Glutathione reductase assay (GSR)
Glutathione reductase activity was determined by
method of Carlberg and Mannervik [22]. The reaction
mixture consisted of 1.65 ml phosphate buffer: (0.1 mol;
pH 7.6), 0.1 ml ethylenediaminetetraacetic acid (EDTA)
(0.5 mmol), 0.05 ml oxidized glutathione (1 mmol),
0.1 ml nicotinamide adenine dinucleotide phosphate
(NADPH) (0.1 mmol) and 0.1 ml of homogenate in a
total volume of 2 ml. Enzyme activity were quantitated
at 25°C by measuring disappearance of NADPH at
340 nm and was calculated as nmol NADPH oxidized/
Table 1 Showing IL and STL
Treatment IL STL
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6.22 × 103 M-1 cm-1.Control 28 ± 3 101 ± 32
SA50 24 ± 3 108 ± 50
SA100 28 ± 7 218 ± 50*
The effect of orally administration of 50 and 100 mg SA extract/kg BW on
initial latency (IL) and step-through latency (STL) in the double trial step-
through test. Asterisk (*) indicates significant difference from the control
littermates (n = 10/group)Glutathione peroxidase assay (GSH-Px)
Glutathione peroxidase activity was assayed by the
method of Mohandas et al. [23] (1984). The reaction
mixture consisted of 1.49 ml phosphate buffer (0.1 mol;
pH 7.4), 0.1 ml EDTA (1 mmol), 0.1 ml sodium azide
(1 mmol), 0.05 ml glutathione reductase (1 IU/ml),
0.05 ml GSH (1 mmol), 0.1 ml NADPH (0.2 mmol),
0.01 ml H2O2 (0.25 mmol) and 0.1 ml of homogenate in
a total volume of 2 ml. The disappearance of NADPH at
340 nm was recorded at 25°C. Enzyme activity was cal-
culated as nmol NADPH oxidized/min/mg protein using
a molar extinction coefficient of 6.22 × 103 M-1 cm-1.Reduced glutathione assay (GSH)
Reduced glutathione was estimated by the method of
Jollow et al. [24], using DTNB as a substrate. The yellow
color developed was read immediately at 412 nm and
expressed as μmol GSH/g tissue.Figure 1 In vitro AChE inhibitory activity of SA (5–150 μg/ml)
extract and Galanthamine (1–32 μM).Estimation of a lipid peroxidation assay (TBARS)
The assay for lipid peroxidation was carried out follow-
ing the modified method of Iqbal et al. [25]. The reaction
mixture in a total volume of 1.0 ml contained 0.58 ml
phosphate buffer (0.1 mol; pH 7.4), 0.2 ml homogenate
sample, 0.2 ml ascorbic acid (100 mmol), and 0.02 ml
ferric chloride (100 mmol). The reaction mixture was
incubated at 37°C in a shaking water bath for 1 h. The
reaction was stopped by addition of 1.0 ml 10%
trichloroacetic acid. Following addition of 1.0 ml 0.67%
thiobarbituric acid, all the tubes were placed in boiling-
water bath for 20 min and then shifted to crushed ice-
bath before centrifuging at 2500 × g for 10 min. The
amount of TBARS formed in each of the samples was
assessed by measuring optical density of the supernatant
at 535 nm using a spectrophotometer against a reagent
blank. The results were expressed as nmol TBARS/min/
mg tissue at 37°C using a molar extinction coefficient of
1.56 × 105 M-1 cm-1.Statistical analysis
Data were expressed as standard error mean (Mean ±
SEM) and one-way analysis of variance (ANOVA). The
least significant difference (LSD) was determined using
post hoc testing for inter group comparisons at a prob-
ability level of 0.05% and 0.01%. SPSS ver 14.0 (Chicago,
IL, USA) and Microsoft Excel 2003 (Roselle, IL, USA)
were used for the statistical and graphical evaluations.
Results
In vitro analysis of SA on AChE activity
In order to check the direct inhibition of AChE, SA and
galanthamine are used. Acetylcholinesterase degrades the
neurotransmitter acetylcholine, producing choline and
an acetate group. Figure 1 presents that SA exhibitedTable 2 Showing body weight before and after treatment
and wet brain weight
Treatment Control SA50 SA100
Body weight before treatment (g) 186.2 ± 3.4 183.6 ± 4.2 188.2 ± 7.9
Body weight after treatment (g) 200.0 ± 5.4 189.5 ± 3.8 195.8 ± 7.2
Wet brain weight (mg) 362.2 ± 3.5 361.5 ± 5.1 357.1 ± 3.4
Mean ± S.E.M values (n = 10/group)
Table 3 Effect of orally Sonchus asper (SA) administration
for 7 days on ex vivo acetylcholinesterase (AChE) activity
(mol/min/g of tissue protein) in rat brain
Treatment Salt soluble (SS)-AChE Detergent soluble (DS)-AChE
Control 0.175 ± 0.0057 0.889 ± 0.074
SA50 0.101 ± 0.002* 0.525 ± 0.031**
SA100 0.074 ± 0.010** 0.300 ± 0.051**
* p< 0.05 significant difference from control
** p< 0.01 significant difference from control
The AChE activity for each group denotes mean ± S.E.M values
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ml while galanthamine an alkaloid extracted from
Galanthus nivalis with an IC50 1.17 μM.Effect of SA extracts on the behavioral study
The changes of SA extract injected orally to rats for six
days on the step-through learning capability is shown in
Table 1. These changes are shown as the mean(s) of IL
and STL for rats of each group. The STL involves rela-
tive resistant stimuli and is a direct measure of passive
avoidance behavior. In the control, SA50 and SA100
groups, the IL was not significantly different (28 ± 3, 24
± 3 and 28 ± 10 s), indicating that all groups behaved the
same in the training trial. However, the SA100 group
exhibited a significant increase (p> 0.05) in STL to 218
± 50 s, 1 day after the acquisition trial, as compared to
the control group (101 ± 32 s). No significant difference
was observed in the SA50 group in comparison to the
control group. Apparently, the SA extracts of 100 mg/kg
b.w. facilitated learning in comparison to the control
group, as is evident by the delay of transfer in the dark
chamber.Animal body and brain weight
No significant changes were observed in body weight of
treated and control rats before, and after the administra-
tion of the SA extracts for seven days. Similarly, no con-
siderable differences in the wet weight of the whole brain













Control 11.0 ± 0.25 7.18 ± 2.8 43.3 ± 3.58 174.5 ± 2
SA50 15.5 ± 2.8* 13.5 ± 1.4** 55.3 ± 1.85* 203.3 ± 1
SA100 14.0 ± 1.12* 18.3 ± 1.7 ** 65.3 ± 5.14** 218.0 ± 1
* p< 0.05 significant difference from control littermates (n = 10/group)
** p< 0.01 significant difference from control littermates (n = 10/group)
The rats brain biochemical parameters are expressed as mean ± S.E.M valuesThe ex vivo effect of SA extracts on brain AChE activity
In order to determine AChE levels in the brain of rats,
the soluble salt part (SS) and detergent soluble part (DS)
fractions of brain homogenates were assayed using the
colorimetric method of Ellman et al. [17] (Table 3).
Short-term SA administration (SA50 and SA100)
resulted in a significant decrease in AChE specific activ-
ity in both SS and DS fractions as compared to control.Effect of SA extracts on brain oxidative status
Table 4 shows changes in brain activities of antioxidant
enzymes, glutathione and TBARS contents in all the ex-
perimental groups of rat. Administration of SA signifi-
cantly (p< 0.05) altered the concentration of SOD, CAT
and TBARS in a dose-dependent way. In particular, SA
administration at 100 mg/kg b.w. almost reduced the
concentration of TBARS in brain tissue. Additionally, the
levels of GSH and activities of GST, GSR and GSHpx
were significantly (p< 0.05) increased in the brain tissue
of SA50 and SA100-treated rats.Discussion
The present study has been carried out using rats for in-
vestigation of learning task. The passive avoidance task is
a fear-aggravated test used to evaluate learning and
memory in rodent models of CNS disorders. In this test,
subjects learn to avoid an environment in which an aver-
sive stimulus (such as a foot-shock) was delivered. On
5th day the IL to enter the dark chamber is measured as
a control for visual ability and motor activity. In our ex-
periment, the mean IL values did not differ among the
different groups. The STL is a measure of the memory of
the aversive experience. The mean STL of rat treated
with the high concentration of the SA extract (SA100)
was significantly higher than those of the other groups
on day 6. These results are in agreement with recent
reports on the long-term memory enhancing effect in
the inhibition avoidance test of dietary supplementation
with Vaccinium ashei (Ericaceae) (rabbiteye blueberries)
of 3-month-old mice for 30 days [26]. Data of the














0.7 115.8 ± 26.11 64.5 ± 10.7 184.5 ± 8.7
0.3** 139.8 ± 13.3 * 88.0 ± 8.3* 200.3 ± 7.3*
0.5 ** 150.8 ± 11.5** 91.8 ± 10.0** 208.0 ± 10.0**
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ports the ideas, which might be due to a decrease in
gene transcription, translation and enhance cholinergic
activity thereby improving cognitive function [27]. AChE
activity was decreased in both SS and DS fractions, with
significant effects in rats treated with SA 100 comparatively
SA50 rats treated group. Oxidative stress and antioxidant
system play an important role in pathophysiological cere-
bral changes. Evaluation of the protective effect Sonchus
asper on rat brain oxidative stress parameters and antioxi-
dant mechanisms was an important aim of our study. The
activity of SOD is a sensitive index in oxidative damage as
it scavenges the superoxide anion to form hydrogen perox-
ide leading to diminish the toxic effects. The catalase is en-
zymatic antioxidants, widely distributed in all animal
tissues that decompose hydrogen peroxide and protect the
tissue from highly reactive hydroxyl radicals. Data revealed
that administration of both SA50 and SA100 increased the
activity of SOD and CAT as reported during supplementa-
tion Sonchus asper in rat [8].
Glutathione reduced, glutathione reductase and glutathi-
one-S-transferase is thought to be the fundamental antioxi-
dant enzymes, for they are closely related to the direct
elimination of reactive oxygen species. Therefore, the reduc-
tion in the activity of these enzymes may result in a number
of deleterious effects due to the accumulation of superoxide
radicals and hydrogen peroxide, linked with neurodegenera-
tive diseases [28]. Supplementation of SA100 and SA50 for
seven days improved the activity, showing protection
against free radicals. From these results, it was inferred that
administration of SA in healthy rat attenuated brain oxida-
tive damages, increased activity of antioxidant enzymes,
GSH and AChE while decreased TBARS level. These anti-
oxidant effects of SA were might be associated with the en-
hancement in performance in the passive avoidance
behavioral test. Although the mechanisms underlying these
effects are still unknown and require more pharmacological,
neurochemical and pharmacokinetic research to establish
any therapeutic advantage. However excessive use of SA is
could be suggested for the prevention of cognitive decline
during aging and neurodegenerative disease.Competing interests
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